GlaxoSmithKline | Despesas Operacionais



Operating Expenses Alterar Data
AbbVie USD 9.71B 96M 2025-06
Alcon AG USD 2.01B 102M 2025-03
Almirall EUR 517.43M 265.53M 2025-06
Amgen USD 6.52B 337M 2025-06
argenx SE USD 744.12M 92.38M 2025-06
AstraZeneca USD 10.95B 1.04B 2025-06
Bayer EUR 10.73B 688M 2025-06
Biogen USD 1.79B 326.1M 2025-06
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Eli Lilly USD 8.54B 1.22B 2025-06
Fresenius EUR 5.02B 57M 2025-06
Fresenius Medical Care EUR 4.36B 189M 2025-06
Galapagos EUR 122.32M 111.37M 2025-06
Genmab DKK 565M 38M 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
GlaxoSmithKline GBP 5.96B 663M 2025-06
Glaxosmithkline GBP 7.42B 408M 2024-12
GRIFOLS EUR 1.54B 24.64M 2025-06
Hikma Pharmaceutical USD 1.31B 63M 2024-12
Lonza CHF 3.09B 564M 2024-12
Merck EUR 4.22B 49M 2025-06
Merck USD 9.44B 217M 2025-06
Novartis USD 9.97B 1.02B 2025-06
Novo Nordisk 42.77B 3.48B 2025-06
Orion EUR 311.9M 35.2M 2025-06
Pfizer USD 11.62B 1.58B 2025-06
Philips EUR 3.85B 93M 2025-06
Recordati EUR 493.93M 9.74M 2025-06
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 9.02B 702M 2025-06
Smith & Nephew USD 2.52B 133M 2025-06
UCB EUR 2.36B 108M 2024-12


GlaxoSmithKline Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.